$MNKD An Epinephrine surprise would be nice. We are at the end of the timeline Castagna himself gave several years back... "Mike Castagna, MannKind’s chief commercial officer, told The American Journal of Managed Care that while “it’s a different pathway,” there would be an opportunity to bring the product to market at a less expensive price. He said the development timeline was 24 to 36 months." Published on: September 01, 2016
  • 15
  • 3